Show This guideline was developed by a multidisciplinary expert panel: Wright D et al with the support of a grant from Rosemont Pharmaceuticals Ltd. See bottom of page for full disclaimer. In this summary IntroductionPatients with long-term conditions requiring feeding tubes are frequently managed in the community and looked after by primary care clinicians. Carers are also increasingly involved in the administration of medicines in the community instead of nurses. Enteral tubes are primarily designed for food and liquid administration: the administration of medicines via enteral tubes is complex and potentially prone to error. Blockage of enteral tubes is a common problem and can have negative impacts for patients and healthcare professionals (Box 1).
Patients
Prescribers/healthcare professionals
Most medicines are not licensed or designed for administration via enteral tubes and, therefore, evidence to support delivery via this route is frequently limited and guidance is based on best practice. Where tablets and capsules are prescribed, these have to be reformulated by crushing or dispersing the contents in liquid prior to dosing. In some instances (for example, modified release or enteric-coated medicines), this may be clinically unsafe; in other instances, inadequate or inappropriate crushing or dispersing can result in tube blockage. While the use of liquid medicines may result in fewer tube occlusions, adequate flushing of tubes before, during, and after administration is recommended for all medication formulations when administered via this route. Manipulated formulations may have unanticipated interactions with feeding products that are not covered by the summary of product characteristics, as they were not intended to be given in this manner. Even simple and seemingly innocuous ingredients can cause problems when a drug is taken out of its capsule or a tablet is crushed, exposing the active ingredients before they reach the stomach and increasing the surface area available for drug interaction. Some drug particles may also adhere to the inside of the tube, reducing the dose actually received by the patient. Licensed formulations that have been tested specifically for use in enteral tubes to identify drug loss on administration, potential for blockage, and ideal/minimum flush volumes are increasingly available. Crushing or dispersing most medicines prior to administration renders the medicine unlicensed as it no longer resembles the original licensed medication and has been ‘assembled’ by the administrator. As such, liability transfers from manufacturer to prescriber and administrator if the prescriber has authorised the process, or just to the administrator if authorisation has not been provided. Manipulation of oral medicines and their administration via enteral tubes without informing the patient could be misconstrued as covert administration. Box 2 summarises the legal implications of moving from oral administration of drugs to administration via enteral feeding tubes. Box 2: Legal implications of moving from oral administration of drugs to administration via enteral feeding tubes
Enteral tube feeding
Care arrangements
Medicines
Figure 1 provides an algorithm to guide prescribing decisions in patients discharged with enteral feeding tubes. Safe administration of medicines via enteral feeding tubes
Figure 2 provides an algorithm to guide enteral tube administration of medicines. Blocked feeding tubes
When to seek advice and refer for specialist help
Useful resourcesabout this working party guideline…
|